跳至主要内容
临床试验/CTRI/2021/09/036991
CTRI/2021/09/036991已完成Unknown

PMOS to evaluate the safety and efficacy of gentle baby wipes_extra large wipes in 0-36 months babies

Himalaya Wellness Company24 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2021年10月18日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
500
试验地点
24
主要终点
To evaluate the safety and efficacy of Test Product in study population.

研究概览

简要总结

STUDY OBJECTIVE: Toevaluate the safety and efficacy of gentle baby wipes in 0-36 months babies

STUDYDESIGN: An open label, post marketing observational study.

Study Methodology:

• Parents/LegallyAcceptable Representatives (LARs) of the baby will be provided with theinformed consent document and explained about the study in detail.

• Babies who fulfilthe selection criteria will be enrolled into the study after written informedconsent.

• The subject’sparent /LAR will be provided with The Himalaya gentle baby wipes/extra-largewipes, and they will be instructed on the use the product by the study doctor/coordinator.

• Assessments willbe performed on Day 1/baseline and at the end of the study visit (Day 15) asper the schedule of events.

• If subjects scorefor Local intolerance is scored 1= Mild, 2=Moderate, 3=Severe, then theundesirable effect page to be completed.

• All undesirableeffects to be followed up till the event is stabilized or 7days whichever isearlier

Study duration: Thisstudy is planned for 15 days. The subjects must use the test product for all 14days.

Number of Subjects:500 subjects will be enrolled.

Study Site: The studywill be conducted at Approximately 25 sites.

Directions to Use: Pull out Wipes andgently clean the baby, carefully reseal the pack flap to keep wipes fresh andmoist for the future (Use 1 extra-large baby wipes to clean whole body).

研究设计

研究类型
Observational

入排标准

年龄范围
0.00 Day(s) 至 36.00 Month(s)(—)
性别
All

入选标准

  • •Subjects in the age group of 0 to 36 months -inclusive of both genders
  • •Subjects in general good health as determined from a recent medical history and physical examination
  • •Subjects mother/legal representative, preferably mother willing to give a voluntary written informed consent and agree to comply with the study protocol.

排除标准

  • •A known history or present allergic condition that may require medical attention
  • •Chronic illness which may influence the cutaneous assessment
  • •Subjects not willing to stop the use of other wipes during study period.

结局指标

主要结局

To evaluate the safety and efficacy of Test Product in study population.

时间窗: Study duration: This study is planned for 15 days.

次要结局

  • Not Applicable(Not Applicable)

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (24)

Loading locations...

相似试验